- Home
- MDGL vs FBIN Comparison
MDGL vs FBIN Comparison
Compare MDGL & FBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- FBIN
- Stock Information
- Founded
- MDGL 2011
- FBIN 1988
- Country
- MDGL United States
- FBIN United States
- Employees
- MDGL N/A
- FBIN N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- FBIN Building Products
- Sector
- MDGL Health Care
- FBIN Consumer Discretionary
- Exchange
- MDGL Nasdaq
- FBIN Nasdaq
- Market Cap
- MDGL 6.8B
- FBIN 6.1B
- IPO Year
- MDGL N/A
- FBIN N/A
- Fundamental
- Price
- MDGL $275.26
- FBIN $50.38
- Analyst Decision
- MDGL Strong Buy
- FBIN Buy
- Analyst Count
- MDGL 10
- FBIN 12
- Target Price
- MDGL $420.63
- FBIN $79.42
- AVG Volume (30 Days)
- MDGL 335.5K
- FBIN 3.1M
- Earning Date
- MDGL 05-01-2025
- FBIN 05-06-2025
- Dividend Yield
- MDGL N/A
- FBIN 1.98%
- EPS Growth
- MDGL N/A
- FBIN 4.88
- EPS
- MDGL N/A
- FBIN 3.42
- Revenue
- MDGL $317,383,000.00
- FBIN $4,532,500,000.00
- Revenue This Year
- MDGL $285.43
- FBIN $0.41
- Revenue Next Year
- MDGL $63.77
- FBIN $3.89
- P/E Ratio
- MDGL N/A
- FBIN $14.74
- Revenue Growth
- MDGL N/A
- FBIN N/A
- 52 Week Low
- MDGL $200.63
- FBIN $47.21
- 52 Week High
- MDGL $377.46
- FBIN $90.54
- Technical
- Relative Strength Index (RSI)
- MDGL 38.56
- FBIN 42.56
- Support Level
- MDGL $265.39
- FBIN $49.56
- Resistance Level
- MDGL $275.54
- FBIN $51.80
- Average True Range (ATR)
- MDGL 11.39
- FBIN 1.57
- MACD
- MDGL -1.08
- FBIN -0.22
- Stochastic Oscillator
- MDGL 24.12
- FBIN 10.35
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About FBIN Fortune Brands Innovations Inc.
Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.3 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $723 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.